ME/CFS patients in Germany criticize inadequate medical care

Patients suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Germany are reporting significant gaps in medical care. While some medications are currently used via off-label prescriptions, a spokesperson for the Long Covid Germany initiative stated that these treatments are not widely utilized and often provide limited benefits.

Patients have reported difficulty managing the high burden of side effects, which can sometimes lead to a worsening of their condition. Due to a lack of current scientific knowledge, it remains difficult to predict which patients will benefit from specific medications and which will experience adverse reactions.

Stella Merendino, a member of the Bundestag for Die Linke, has called on the German federal government to increase research funding and advance clinical studies. While the government has cited a lack of scientific evidence as a barrier, Merendino argued that this should not serve as a justification for political inaction regarding the development of specific treatments and methods for cost coverage.